Cytosorbents
CTSO
#9832
Rank
A$61.18 M
Marketcap
A$0.97
Share price
1.69%
Change (1 day)
-43.36%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$20.21 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.97 Million. In 2024 the company made an earning of -A$32.09 Million, an increase over its 2023 earnings that were of -A$41.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$20.21 Million-37.03%
2024 -A$32.09 Million-22.49%
2023 -A$41.4 Million-13.52%
2022 -A$47.87 Million34.04%
2021 -A$35.72 Million182.17%
2020 -A$12.66 Million-55.97%
2019 -A$28.75 Million14.17%
2018 -A$25.18 Million95.14%
2017 -A$12.91 Million-22.32%
2016 -A$16.61 Million39.1%
2015 -A$11.94 Million-12.89%
2014 -A$13.71 Million89%
2013 -A$7.26 Million26.65%
2012 -A$5.73 Million-26.02%
2011 -A$7.74 Million-288.45%
2010 A$4.1 M-4.17%
2009 A$4.28 M-287.19%
2008 -A$2.29 Million-47.12%
2007 -A$4.33 Million41.78%
2006 -A$3.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$4.61 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.09 B-6,233.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
A$78.36 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA